Industry News
Listed below is the most recent news in the drug industry. You will find press releases and announcements from large pharmaceuticals as well as from the FDA and other sources. The news is sorted by date as it is released, giving you immediate access to the most relevant information — all in one place. Bookmark this page if you'd like to keep current on the news in the drug industry.
Channel: Drugs.com - Pharma News+ show more articles - show fewer articles
- Feb 06, 2012: Cipher achieves sales milestone for Lipofen
- Feb 06, 2012: Cegedim Strategic Data (CSD) Tracks Pharmaceutical Companies' Print Advertising Investments
- Feb 06, 2012: Merck Provides Update on Development Program for Suvorexant, an Investigational Orexin Receptor Antagonist for the Treatment of Insomnia
- Feb 06, 2012: Anacor Pharmaceuticals Announces That Its Partner GSK Has Voluntarily Paused Enrollment of Ongoing GSK ?052 Phase 1 and 2 Clinical Trials
- Feb 06, 2012: Astellas Pharma Inc.: Reorganization of Astellas?Global Management Structure
- Feb 06, 2012: Five Years After HPV Vaccine Law, Virginia Remains Split
- Feb 06, 2012: Pharma cos need to compensate clinical trial victims, rules govt
- Feb 06, 2012: Cardinal Health Statement Regarding Temporary Restraining Order to Avoid Disruption in Controlled Medicine Shipments From Florida
- Feb 03, 2012: Cardinal Health Inc. Seeks Restraining Order to Avoid Disruption in Controlled Medicine Shipments from Florida
- Feb 03, 2012: Montreal Pharma Research Cluster Threatened Again As AstraZeneca Closes Lab
- Feb 03, 2012: Federal Court Dismisses Whistleblower Lawsuit Against Millennium Laboratories
- Feb 03, 2012: Idenix Announces Removal of the Partial Clinical Hold on HCV Nucleotide Inhibitor, IDX184
- Feb 03, 2012: Bristol-Myers Squibb Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Inhibitex, Inc.
- Feb 03, 2012: Gilead Sciences Announces Fourth Quarter and Full Year 2011 Financial Results
- Feb 03, 2012: Drug maker Alkermes Fiscal 3Q Loss Widens
- Feb 03, 2012: Gilead Sciences 4Q Profit Rises on HIV Drug Sales
- Feb 03, 2012: Vertex Posts 4Q Profit on Growing Incivek Sales
- Feb 03, 2012: Merck KGaA and Threshold Announce Global Agreement to Co-Develop and Commercialize Phase III Hypoxia-Targeted Drug TH-302
- Feb 02, 2012: Mikulski Bill Would Speed Approval of New Drugs By FDA
- Feb 02, 2012: Allergan Reports Fourth Quarter 2011 Operating Results
- Feb 02, 2012: Are We Sure Our Drugs Are Safe?
- Feb 02, 2012: Novo Nordisk increased operating profit by 18% in 2011
- Feb 02, 2012: Merck Announces Full-Year and Fourth-Quarter 2011 Financial Results
- Feb 02, 2012: AstraZeneca?s New Restructuring Initiatives to Drive Productivity and Support Innovation
- Feb 02, 2012: Agennix AG Halts Phase II/III OASIS Trial in Severe Sepsis
- Feb 01, 2012: Independent Survey of US Oncologists by National Analysts Worldwide Finds Drug Shortages and Escalating Costs Result in Grave Health Consequences
- Feb 01, 2012: Which Pharma company is leading the charge in Productive Innovation for 2012?
- Feb 01, 2012: Pfizer EVP Among Obama 'Top Money Bundlers'
- Feb 01, 2012: D&R Acquires LATHIAN to Create Leading Multichannel Marketing Agency
- Feb 01, 2012: Study: E-Prescribing Shown to Improve Outcomes and Save U.S. Healthcare System Billions of Dollars
